# data[].attributes.body
Gary Warren, President and CEO

# data[].attributes.body
ivWatch Model 400 is a new FDA-cleared medical device that uses an infrared sensor on the patient’s skin to continuously monitor changes in subcutaneous tissue to detect early IV infiltration. If changes in the tissue are consistent with infiltration (fluid leaking into surrounding tissue) the device will visually and audibly alarm, alerting clinicians to the possible extravasation event. This device serves as an aid for constant IV site monitoring to reduce patient harm through IV failure.

# data[].attributes.attachment_link.title
ivWatch Model 400 Product Overview For Adult and Pediatric Patients

# data[].attributes.body
* Avoids harm to patients by reducing peripheral IV infiltration/extravasation hospital acquired condition
* Reduces hospital costs in the event of an extended hospitalization due to an infiltration event
* May increase HCAHPS patient satisfaction scores
* Avoids potential legal issues for serious adverse events
* May reduce more invasive procedures (PICC lines)
* Especially useful in pediatric patients who have small, fragile veins, limited communication, and frequent movement
* Assists in patient monitoring
* Monitor tracks data for upload to the EMR
* ivWatch offers an evaluation program to trial the product free of cost

# data[].attributes.body
* The ivWatch patient monitor is large and must be mounted to an IV pole which may not be accessible or easily fit with multiple IV channels
* False alarming could contribute to alarm fatigue
* Initial cost of device (unable to obtain exact price quote from company)
* May not be properly utilized without timely staff training

# data[].attributes.body
ivWatch is an excellent product which could drastically improve the country’s current 50% IV failure rate when 80% of hospitalized patients get an IV. In clinical validation studies, the ivWatch detected 80% of infiltrations on average 29 hours before a clinician 95% of the time. ivWatch is useful across multiple settings including: pediatrics who have fragile veins and frequent movement, the OR where drapes may cover IV sites, the ICU where critically ill patients may not be able to communicate, oncology where medications are highly vesicant, and the emergency department where clinicians are prioritizing multiple simultaneous patient needs. Every IV failure is a potential risk for loss of limb through tissue necrosis, prolonged hospital stays, increased healthcare cost or even a patient's life. This continuous monitoring device revolutionizes IV safety while providing clinicians with peace of mind.

# data[].attributes.body
“Improving Patient Safety in Vascular Access with the Early Detection of IV Infiltration and Extravasation Events.” IvWatch, www.ivwatch.com/.

“IvWatch Detects IV Infiltrations and Extravasations: Interview with Gary Warren, President and CEO |.” Medgadget, 27 Mar. 2018, www.medgadget.com/2018/03/ivwatch-detects-iv-infiltrations-and-extravasations-interview-with-gary-warren-president-and-ceo.html.

# data[].attributes.body
As the team leader I will utilize my achiever strength to lead the team to success. Abraham as arranger will be helpful in organizing and assigning team members to specific jobs based on individual strengths for maximum productivity. David as deliberative will be beneficial in using good judgement for decision-making processes while anticipating potential project obstacles. Daisy as developer will be valuable in cultivating the strengths of other team members and holding the group accountable to our final project goals. Fernando with his focus strength will be an important contributor for setting goals, prioritizing tasks and keeping the group on track with deadlines. Matthew as maximizer will be a positive influence in setting a standard of excellence and ensuring important project details are not missed.